Has there been studies regarding psychoactive piperazine structure-activity relationship? As main (psychoactive) piperazines in the market can be classified to two groups:
- Phenylpiperazines
So, what is known is that phenethylamine SAR is irrevalent to piperazine's, as report keeps coming. but what about...
Any information on this?
- Phenylpiperazines
- 1-phenylpiperazine : Has a report on erowid on misconception as BZP
- 1-(3-chlorophenyl)piperazine : mCPP
- 1-(3-trifluoromethylphenyl)piperazine : TMFPP
- 1-(4-methoxyphenyl)piperazine : MeOPP
- 1-benzylpiperazine : BZP
- 1-benzyl-4-methylpiperazine : reported to be more mellow to BZP
- 1-(4-bromo-2,5-dimethoxybenzyl)piperazine : (found to be inactive)
- 1-(benzo[1,3]dioxol-5-ylmethyl)piperazine : MDBZP - only have negative impact reports
So, what is known is that phenethylamine SAR is irrevalent to piperazine's, as report keeps coming. but what about...
- Chain length : phenyl -> benzyl -> phenethyl -> phenylpropyl? benzylpiperazines seems to be more stimulating than phenylpiperazines. What about phenethyl? or would phenylpropyl possess (some) opioid activity?
- Aromatic ring: is that important comparing to if it is some bulky alkyl groups, cyclics or long chain ones? (in the same fashion as amphet,propylhexedrine,dimethylamylamine)
- Substituents : including both at the PP ring and the attached group
Any information on this?
Last edited:
